Journal of Asthma · 2021 · 15 citations · 11 references
PharmacyPharmacologyPharmacotherapyGeriatric PharmacologyGeriatric PharmacotherapyImmunotherapyAsthma ManagementAsthma PharmacotherapyImmunotherapy SafetyBiologic Therapy For AsthmaBiological TreatmentMedian AgeOmalizumab TherapySafety Of Asthma MedicationsSerious Adverse EventsSevere Asthma ManagementSevere Asthma Treatment
Objective To assess the safety of biological therapy for severe T2 asthma (omalizumab, mepolizumab, benralizumab and reslizumab) under real-life conditions in elderly patients older than 70 years.Methods Retrospective data collection including clinical characteristics, comorbidities, treatment, disease control and adverse events (AE) of all patients with severe asthma on biological therapy older than 70 years seen in the Severe Asthma Unit of our hospital.Results Of 147 patients with severe asthma being treated with biologics, 21 patients older than 70 years were included. The median age of these patients was 76.3 years (range 71–86) and the majority were women (n = 18, 85.7%). There were 9 patients (42.9%) who experienced an AE related to biological treatment. Four (44.4%) were in treatment with omalizumab, two (22.2%) with mepolizumab, two patients (22.2%) with reslizumab and one (11.1%) with benralizumab. The median FEV1 (%) was 66%. These patients had a considerably higher body mass index (BMI). No significant differences were found for any other variable. Most of the AE reported were considered mild with the exception of one case of systemic AE (anaphylaxis) associated with omalizumab.Conclusion This study indicates that the prescription of biological therapy in elderly patients with severe asthma seems to be safe. More evidence is needed in this particular population.
11
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
Ian Pavord, Pascal Chanez, Gerard J. Criner et al. · New England Journal of Medicine · 2017 · 591 citations · Full text
Adherence to Asthma Therapy in Elderly Patients
Andrzej Bożek, Jerzy Jarząb · Journal of Asthma · 2010 · 93 citations